Trial Profile
The influence of raltegravir on pravastatin pharmacokinetics in healthy volunteers (GRAPPA)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Pravastatin (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections; Hyperlipidaemia
- Focus Pharmacokinetics
- Acronyms GRAPPA
- 15 Apr 2010 Results published in Journal of acquired immune deficiency syndromes.
- 21 Oct 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 21 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.